Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.
<h4>Background/aims</h4>In a recent study, attenuation imaging (ATI) with ultrasound was used as a new approach for detecting liver steatosis. However, although there are many studies on ATI and controlled attenuation parameter (CAP) that prove their practicability, there are few studies...
Guardado en:
Autores principales: | Po-Ke Hsu, Li-Sha Wu, Wei-Wen Su, Pei-Yuan Su, Yang-Yuan Chen, Yu-Chun Hsu, Hsu-Heng Yen, Chia-Lin Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0639cd18204a473998ee5e8335dcb11e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The clinical utility of FibroScan® as a noninvasive diagnostic test for liver disease
por: Wilder J, et al.
Publicado: (2014) -
Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch
por: Serra JT, et al.
Publicado: (2020) -
Direct comparison of the FibroScan XL and M probes for assessment of liver fibrosis in obese and nonobese patients
por: Durango E, et al.
Publicado: (2013) -
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases
por: Hideki Fujii, et al.
Publicado: (2021) -
Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
por: Hsu-Heng Yen, et al.
Publicado: (2021)